Quick Answer
VivoSim Labs, INC. reported Cash and Equivalents of $11.31 million for fiscal year 2025.
VivoSim Labs, INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $11.31M | +289.9% |
| 2024 | $2.90M | -81.0% |
| 2023 | $15.30M | -46.6% |
| 2022 | $28.68M | -23.3% |
| 2021 | $37.36M | +36.6% |
| 2020 | $27.36M | -25.0% |
| 2019 | $36.48M | -16.6% |
| 2018 | $43.73M | -30.3% |
| 2017 | $62.75M | +1.1% |
| 2016 | $62.09M | +23.8% |
| 2015 | $50.14M | +4.1% |
| 2014 | $48.17M | +208.2% |
| 2013 | $15.63M | +5.5% |
| 2012 | $14.82M | +43.1% |
| 2012 | $10.35M | +2945.0% |
| 2011 | $340.0K | +19.3% |
| 2010 | $285.0K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $4.29M | +269.3% | -35.8% |
| September 30, 2025 | $6.68M | +110.4% | -26.3% |
| June 30, 2025 | $9.05M | +46.4% | -20.0% |
| March 31, 2025 | $11.31M | +289.9% | +874.3% |
| December 31, 2024 | $1.16M | -78.1% | -63.4% |
| September 30, 2024 | $3.17M | -58.3% | -48.7% |
| June 30, 2024 | $6.19M | -42.5% | +113.3% |
| March 31, 2024 | $2.90M | -81.0% | -45.2% |
- VivoSim Labs, INC. showed an increase of +289.9% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2010–2025 period, VivoSim Labs, INC.’s cash and equivalents has grown by 3869.1% (from $285.0 thousand to $11.31 million).
- The most recent figure is from VivoSim Labs, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on June 5, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: